HHS Secretary Xavier Becerra (Patrick Semansky/AP Images)
March 15, 2023 06:25 AM EDTUpdated 10:02 AM
Pharma
Law

Five Pfiz­er drugs among first 27 now sub­ject to Medicare in­fla­tion re­bates, HHS says

Zachary Brennan

Senior Editor

The De­part­ment of Health and Hu­man Ser­vices (HHS) on Wednes­day un­veiled the first set of 27 Part B pre­scrip­tion drugs, in­clud­ing five from Pfiz­er, that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times